Please login to the form below

Not currently logged in
Email:
Password:

Boyds expands regulatory affairs team

Céline Courtay-Cahen joins the pharma and biotech consultancy

Boyd Consultants Celine Courtay-CahenBoyd Consultants has appointed Céline Courtay-Cahen as a regulatory affairs consultant, based out of its Cambridge, UK office.

In her new role, Courtay-Cahen will manage projects including orphan drug designations, clinical trial applications and marketing authorisation applications.

She joins the consultancy from Evigo Pharma Consulting, where she also served as a regulatory affairs consultant and worked on a number of gene therapy projects, paediatric products, and in pharmacovigilance.

Prior to this, Courtay-Cahen worked in a various research positions with roles at the Institute of Structural Biology in Grenoble, the faculty of medicine at the Free University of Brussels, and the department of pathology at the University of Cambridge.

Alan Boyd, founder and chief executive officer of Boyd Consultants, said: “I am delighted to welcome Céline to our team at this exciting time. Her expertise will complement that of the team adding more value to our clients.”

17th June 2016

From: Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
PRMA Consulting Ltd

PRMA Consulting is an independent consultancy solving some of the most challenging pricing, reimbursement and market access issues facing international...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics